$72.80 Million in Sales Expected for Control4 Corp (NASDAQ:CTRL) This Quarter

Equities analysts expect that Control4 Corp (NASDAQ:CTRL) will announce sales of $72.80 million for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Control4’s earnings. The lowest sales estimate is $70.96 million and the highest is $75.26 million. Control4 reported sales of $69.23 million in the same quarter last year, which indicates a positive year over year growth rate of 5.2%. The business is scheduled to issue its next earnings report on Thursday, August 1st.

According to Zacks, analysts expect that Control4 will report full year sales of $287.88 million for the current fiscal year, with estimates ranging from $279.79 million to $296.32 million. For the next financial year, analysts expect that the firm will post sales of $317.86 million, with estimates ranging from $305.50 million to $324.28 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Control4.

Control4 (NASDAQ:CTRL) last released its earnings results on Thursday, May 9th. The electronics maker reported $0.13 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.17. The firm had revenue of $60.43 million during the quarter, compared to analysts’ expectations of $61.64 million. Control4 had a net margin of 14.94% and a return on equity of 12.56%. The business’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.21 EPS.



CTRL has been the subject of several research analyst reports. DA Davidson cut shares of Control4 from a “buy” rating to a “neutral” rating and cut their target price for the company from $33.00 to $24.00 in a research note on Thursday, May 9th. ValuEngine upgraded shares of VESTAS WIND SYS/ADR from a “hold” rating to a “buy” rating in a research note on Thursday, May 9th. Maxim Group cut shares of Control4 from a “buy” rating to a “hold” rating in a research note on Monday, May 13th. Cowen restated a “hold” rating on shares of PDL BioPharma in a research note on Thursday, May 9th. Finally, Roth Capital set a $10.00 price objective on shares of Savara and gave the company a “hold” rating in a research note on Tuesday, May 14th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $27.57.

In other news, Director Robert Born sold 3,570 shares of the stock in a transaction on Monday, May 20th. The shares were sold at an average price of $23.64, for a total value of $84,394.80. Following the completion of the transaction, the director now owns 17,867 shares in the company, valued at approximately $422,375.88. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Phil Molyneux sold 23,374 shares of the stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.74, for a total transaction of $554,898.76. Following the sale, the director now owns 42,347 shares of the company’s stock, valued at approximately $1,005,317.78. The disclosure for this sale can be found here. In the last 90 days, insiders sold 28,944 shares of company stock valued at $686,674. Corporate insiders own 2.90% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Flinton Capital Management LLC acquired a new stake in shares of Control4 during the 4th quarter worth about $31,000. Neuburgh Advisers LLC bought a new stake in Control4 during the 4th quarter worth about $37,000. Quantamental Technologies LLC grew its holdings in Control4 by 7,955.4% during the 1st quarter. Quantamental Technologies LLC now owns 4,511 shares of the electronics maker’s stock worth $76,000 after acquiring an additional 4,455 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in Control4 by 192.0% during the 1st quarter. BNP Paribas Arbitrage SA now owns 6,937 shares of the electronics maker’s stock worth $117,000 after acquiring an additional 4,561 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan bought a new stake in Control4 during the 4th quarter worth about $131,000. Institutional investors and hedge funds own 79.87% of the company’s stock.

NASDAQ:CTRL traded up $0.01 during trading hours on Tuesday, hitting $23.84. 203,631 shares of the company traded hands, compared to its average volume of 277,461. The company has a market capitalization of $638.89 million, a PE ratio of 24.83, a price-to-earnings-growth ratio of 2.25 and a beta of 0.40. Control4 has a twelve month low of $15.59 and a twelve month high of $37.62. The stock’s 50-day moving average price is $23.74. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.89 and a quick ratio of 2.74.

Control4 Company Profile

Control4 Corporation provides smart home and business solutions in the United States, Australia, Canada, China, Germany, the United Kingdom, and internationally. The company offers Control4 solution that functions as the operating system of the home, integrating audio, video, lighting, temperature, security, communications, and other devices into a unified automation solution.

See Also: Different Options Trading Strategies

Get a free copy of the Zacks research report on Control4 (CTRL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Control4 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Control4 and related companies with MarketBeat.com's FREE daily email newsletter.